Clinical trials are imperative for testing novel cancer therapies, advancing the science of cancer care, and determining the best treatment…
Gregory Bruich received his Ph.D. from the Department of Economics at Harvard University. His research is in public economics. He was…
Multiclass queueing systems widely used in operations research and management typically experience ambiguity in real-world settings in the…
Overall mortality rates, adjusted for age, sex, and Medicaid status, in Medicare Advantage have been below those in traditional Medicare…
Few studies have used preference-based quality-of-life outcomes to assess how autism spectrum disorders (ASDs) affect children and parents…
How much are low-income individuals willing to pay for health insurance, and what are the implications for insurance markets? Using…
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear.…
Typhoid fever is an acute systemic infectious disease responsible for an estimated 12–20 million illnesses and over 150?000 deaths annually…
This chapter summarizes research in behavioral health economics, focusing on insurance markets and product markets in health care. We argue…
On the thirty-fifth anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies…